Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Tofacitinib Outperforms Azathioprine in Treating Alopecia Areata, New Study Finds Medha Baranwal23 Dec 2024 8:30 PM ISTPakistan: A recent double-blind, randomized controlled trial has provided new insights into the efficacy and safety of two alopecia areata (AA)...
Oral Tofacitinib arrests vitiligo progression and induces repigmentation when combined with phototherapy: Study Aditi21 March 2024 8:00 PM ISTVitiligo is a chronic autoimmune disease that results from the loss of melanocytes, leading to disfiguring skin lesions. This skin condition causes...
JAK inhibitor use in skin conditions associated with elevated odds of the appearance of acne: JAMA Aditi25 Oct 2023 10:30 AM ISTJAK inhibitors usage are increasing in atopic dermatitis, alopecia areata, psoriasis, and vitiligo. Studies suggest that JAK inhibitors may have...
Medical Bulletin 19/September/2023 Isra Zaman19 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Researchers uncover surprising side effects of common diabetes drug MetforminMetformin, a well-established...
JAK inhibitor ruxolitinib promising in reducing severity of rare form of sclerosis: NEJM Aditi7 Jun 2023 9:30 AM ISTA study published in The New England Journal of Medicine has mentioned the results of a clinical series demonstrating the role of Janus kinase (JAK)...
Topical JAK inhibitors effective against atopic dermatitis Jacinthlyn Sylvia13 Feb 2023 8:00 PM ISTA recent systematic analysis reveals that topical JAK inhibitors (JAKi) are both effective and safe for the treatment of atopic dermatitis (AD) in...
Baricitinib effective in cutaneous manifestations of dermatomyositis Dr Manoj Kumar Nayak30 Dec 2022 9:45 AM ISTBaricitinibeffective in cutaneous manifestations of dermatomyositisDermatomyositis(DM) is a rare autoimmune collagen vascular disease with cutaneous...
FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 9:00 AM ISTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
Treating sarcoidosis with JAK inhibitor shows promise in clinical trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTEvery patient in a Yale clinical trial of a new treatment for the disfiguring disease sarcoidosis saw improvement to their skin-and more than half...
Medical Bulletin 29/December/2021 Dr. Nandita Mohan29 Dec 2021 6:32 PM ISTHere are Top Medical stories of the dayViagra use linked to reduced risk of Alzheimer's diseaseA new Cleveland Clinic-led study has identified...
Barcitinib effective in severe nail lichen planus- 1st case report Dr Manoj Kumar Nayak23 Dec 2021 9:00 AM ISTBarcitinib effective in severe nail lichen planus- 1st case report - Lichen planus (LP) is an inflammatory disorder of the skin and mucous...
